Changes in Serum Metabolome Following Low-Energy Diet-Induced Weight Loss in Women with Overweight and Prediabetes: A PREVIEW-New Zealand Sub-Study.

NMR spectroscopy low-energy diet metabolomics obesity polar metabolites prediabetes weight loss

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
24 Jul 2024
Historique:
received: 13 06 2024
revised: 08 07 2024
accepted: 16 07 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

As obesity develops, metabolic changes increase the risk of non-communicable diseases such as type 2 diabetes (T2D). Weight loss is crucial for improving health in T2D and cardiometabolic conditions. However, weight loss rates vary between individuals, even with identical diets or energy restrictions, highlighting the need to identify markers or predictors of weight loss success to enhance intervention outcomes. Using nuclear magnetic resonance (NMR) spectroscopy-based metabolomics, we investigated the change in serum polar metabolites in 28 women with overweight or obesity and prediabetes who completed an 8-week low-energy diet (LED) as part of the PREVIEW (PREVention of diabetes through lifestyle intervention and population studies in Europe and around the World) clinical trial. We aimed to characterize the metabolic shift in substrate oxidation under fixed energy intake (~4 MJ/day) and its relation to weight loss success. Nine of the thirty-four serum metabolites identified significantly changed during the LED phase: 3-hydroxybutyrate,

Identifiants

pubmed: 39195497
pii: metabo14080401
doi: 10.3390/metabo14080401
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : New Zealand Health Research Council and University of Auckland Faculty Re-search Development Fund.
ID : 14/191

Auteurs

Bárbara Relva (B)

NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.

Linda M Samuelsson (LM)

Smart Foods & Bioproducts Group, AgResearch Ltd., Palmerston North 4442, New Zealand.

Iola F Duarte (IF)

Department of Chemistry, CICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.

Ulrike Fasol (U)

Faculty of Medical and Life Sciences, Furtwangen University, 78054 Villingen-Schwenningen, Germany.

Patrick J B Edwards (PJB)

School of Natural Sciences, Massey University, Palmerston North 4442, New Zealand.

Mikael Fogelholm (M)

Department of Food and Nutrition, University of Helsinki, Unioninkatu 44, 00014 Helsinki, Finland.

Anne Raben (A)

Department of Nutrition, Exercise and Sports, University of Copenhagen, Nørre Allé 51, DK-2200 Copenhagen, Denmark.
Department for Clinical and Translational Research, Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Blegdamsvej 9, DK-2100 Herlev, Denmark.

Sally D Poppitt (SD)

Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, 18 Carrick Place, Auckland 1024, New Zealand.

Marta P Silvestre (MP)

NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, 18 Carrick Place, Auckland 1024, New Zealand.
CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.

Classifications MeSH